Common Contracts
1 similar Investment Agreement contracts
VOLUNTARY ANNOUNCEMENT INVESTMENT AGREEMENT WITH ZHENJIANG COMMITTEEInvestment Agreement • November 1st, 2018
This is a voluntary announcement made by Genscript Biotech Corporation (the “Company” , together with its subsidiaries, the “Group” ). The board (the “Board” ) of directors (the “Directors” ) of the Company is pleased to announce that on 12 November, 2019, its indirect wholly-owned subsidiary, GenScript (Hong Kong) Limited 金斯康（香港）有限公司 ( “GS HK” ), entered into an investment agreement with Zhenjiang Economic and Technological Development Zone Management Committee* 鎮江經濟技術開發區管理委員會 (the “Zhenjiang Committee” ), in relation to the investment by the Group into the Jiangsu Genscript Innovative Biological Medicine CMO (Contracted Manufacturing Organization) Project (the “CMO Project” ) in Zhenjiang Economic and Technical Development Zone* 中國鎮江經濟技術開發區 ( “Zhenjiang New Area” ) (the “Investment Agreement” ).
